Tewin Tencomnao | Immunology | Best Researcher Award

Assist. Prof. Dr. Tewin Tencomnao | Immunology | Best Researcher Award

Dean at Chulalongkorn University, Thailand

Assist. Prof. Dr. Tewin Tencomnao is the Head of the Center of Excellence on Natural Products for Neuroprotection and Anti-Ageing at Chulalongkorn University, where he also serves as Assistant Professor in Clinical Chemistry and Dean of the Faculty of Allied Health Sciences. He holds a Ph.D. in Biochemistry and Molecular Biophysics from Virginia Commonwealth University and a B.Sc. in Medical Technology (Honors) from Chulalongkorn University. His research spans drug discovery, natural products, molecular biology, biochemistry, neuroscience, anti-ageing, and mechanisms of neuropsychiatric diseases. Dr. Tencomnao has authored more than 205 publications, accumulating over 10,636 citations, and maintains a strong h-index of 34, reflecting his influence in neuroprotection and natural product research. He has received several prestigious recognitions, including the 2021 Fulbright Thai Visiting Scholar Award (University of Kentucky), the 2020 Outstanding Researcher Award of Chulalongkorn University, the 2015 DMSc Award from the Ministry of Public Health for his groundbreaking work on Rhinacanthus nasutus, and a 2015 international Gold Award for innovation for developing an anti-ageing cream derived from natural resveratrol. He has contributed extensively to scientific literature through numerous book chapters covering medicinal Thai herbs, neuroprotection, phytochemistry, natural anti-ageing compounds, probiotics, and medicinal plant responses to environmental stresses, with recent works published by CRC Press, Taylor & Francis, Elsevier, Springer Nature, and Bentham Science. His scholarly outputs highlight significant advances in natural neuroprotectants, autophagy regulation, medicinal plant proteomics, anti-glutamate neurotoxicity mechanisms, and therapeutic potentials of phytochemicals in ageing and neurodegeneration, establishing him as a leading authority in natural product-based biomedical innovation.

Profiles: Scopus Orcid | Google Scholar

Featured Publications

Areekul, P., Bhunyakarnjanarat, T., Suebnuson, S., Somsri, K., Trakultritrung, S., Taveethavornsawat, K., Tencomnao, T., Boonyasuppayakorn, S., & Leelahavanichkul, A. (2025). Less severe inflammation in cyclic GMP–AMP synthase (cGAS)-deficient mice with rabies: Impact of mitochondrial injury and gut–brain axis. Biology, 14(11), 1583. https://doi.org/10.3390/biology14111583

Alugoju, P., Palanisamy, C. P., Anthikapalli, N. V. A., Jayaraman, S., Prasanskulab, A., Chuchawankul, S., Dyavaiah, M., & Tencomnao, T. (2024). Exploring the anti-aging potential of natural products and plant extracts in budding yeast Saccharomyces cerevisiae: A review. F1000Research, 13, 141669. https://doi.org/10.12688/f1000research.141669.2

Alugoju, P., Bhandare, V. V., Patil, V. S., Krishna Swamy, V. K. D., Borugadda, P. K., & Tencomnao, T. (2024). In silico molecular docking and molecular dynamic simulation of agarwood compounds with molecular targets of Alzheimer’s disease. F1000Research, 13, 130618. https://doi.org/10.12688/f1000research.130618.2

Janpaijit, S., Sukprasansap, M., Tencomnao, T., & Prasansuklab, A. (2024). Anti-neuroinflammatory potential of areca nut extract and its bioactive compounds in anthracene-induced BV-2 microglial cell activation. Nutrients, 16(17), 2882. https://doi.org/10.3390/nu16172882

Pattarachotanant, N., Sukjamnong, S., Rangsinth, P., Chaikhong, K., Sillapachaiyaporn, C., Leung, G. P.-H., Hu, V. W., Sarachana, T., Chuchawankul, S., Tencomnao, T., et al. (2024). Aquilaria crassna extract exerts neuroprotective effect against benzo[a]pyrene-induced toxicity in human SH-SY5Y cells: An RNA-seq-based transcriptome analysis. Nutrients, 16(16), 2727. https://doi.org/10.3390/nu16162727

Sharika, R., Mongkolpobsin, K., Rangsinth, P., Prasanth, M. I., Nilkhet, S., Pradniwat, P., Tencomnao, T., & Chuchawankul, S. (2024). Experimental models in unraveling the biological mechanisms of mushroom-derived bioactives against aging- and lifestyle-related diseases: A review. Nutrients, 16(16), 2682. https://doi.org/10.3390/nu16162682

Tedasen, A., Chiabchalard, A., Tencomnao, T., Yamasaki, K., Majima, H. J., Phongphithakchai, A., & Chatatikun, M. (2024). Anti-melanogenic activity of ethanolic extract from Garcinia atroviridis fruits using in vitro experiments, network pharmacology, molecular docking, and molecular dynamics simulation. Antioxidants, 13(6), 713. https://doi.org/10.3390/antiox13060713

Bartłomiej Ferra | Parasitology | Best Researcher Award

Dr. Bartłomiej Ferra | Parasitology | Best Researcher Award

Institute of Maritime and Tropical Medicine, Poland

Profile

Google Scholar

🎓 Early Academic Pursuits

Bartłomiej Tomasz Ferra’s academic journey began with a Biotechnology degree from the Gdańsk University of Technology in 2010, reflecting early promise in the life sciences. His strong foundational interest in biotechnology advanced into a PhD in Chemical Sciences with a specialization in biotechnology in 2015, which laid the groundwork for his transition into advanced research on parasitic diseases. His academic excellence from the outset has been marked by interdisciplinary thinking and innovation in health-related biotechnological applications.

🧪 Professional Endeavors

Currently serving as Senior Specialist at the Division of Tropical Parasitology, Institute of Maritime and Tropical Medicine, Medical University of Gdańsk, Ferra has held influential roles in both laboratory and collaborative research environments. His work spans parasitology, immunology, molecular biology, and genetic engineering, with a unique focus on tick-borne diseases and Apicomplexa parasites. In addition to spearheading two major research projects and contributing to three others as co-investigator, he also consults on three industry-oriented projects, signifying his adaptability between academia and practical scientific application.

🔬 Research Focus & Scientific Contributions

Ferra’s core research aims to enhance serodiagnostic techniques and develop recombinant protein-based vaccines, particularly against parasitic threats like Toxoplasma gondii. His significant contribution includes the development of chimeric recombinant T. gondii proteins, which can replace native antigens in commercial tests and reduce tissue cyst formation by up to 80% in immunized animal models. His innovations have led to two patents, one of which has already been granted (Patent No. 240086), highlighting real-world translational impact.

🌐 Impact and Collaborations

His extensive collaborations with international institutions—from Portugal’s Universidade Nova de Lisboa to New Zealand’s Lincoln University—reflect a global research footprint. These partnerships have catalyzed knowledge-sharing and technological advancement in molecular parasitology. Editorial responsibilities in special issues of journals like Frontiers in Cellular and Infection Microbiology and International Journal of Molecular Sciences further reinforce his stature as a thought leader in infectious disease research.

📈 Academic Citations and Recognition

Bartłomiej Ferra’s scientific productivity is reflected in 22 articles indexed in Scopus and SCI, with over 300 citations (Scopus) and 286 (SCI). His Scopus h-index of 12 underscores the academic relevance and growing impact of his work within the scientific community. He is also active on platforms such as ORCID, Google Scholar, ResearchGate, and Web of Science, ensuring visibility and engagement across multidisciplinary domains.

💻 Technical Expertise and Certifications

Ferra is certified in risk management methodologies (M_o_R®) and trained in animal experimentation planning and execution, essential for conducting ethical biomedical research. His lab experience spans recombinant protein design, serological assays, and pathogen detection systems—skills that are vital in combating vector-borne and zoonotic diseases.

👨‍🏫 Teaching and Mentorship

Though primarily research-oriented, Ferra’s contributions to knowledge dissemination are also seen through mentorship and collaboration with academic peers across research institutions. His editorial and grant involvement reflects an ability to guide scientific discourse and nurture upcoming research initiatives. His active engagement in specialized academic forums helps train new researchers in niche areas such as tick-borne zoonoses and molecular immunology.

🏅 Legacy and Future Contributions

As a rapidly rising name in the realm of molecular parasitology, Ferra’s work is laying the foundation for next-generation diagnostic tools and vaccines. His interdisciplinary approach and established international collaborations position him to lead large-scale, global health initiatives against parasitic and tick-borne diseases. With a growing record of impactful publications, patents, and translational innovation, he is poised to leave a lasting legacy in biomedical sciences, particularly in the Global South health context.

Selected Publications

Title: Serodiagnosis of Toxoplasma gondii infection in farm animals (horses, swine, and sheep) by enzyme-linked immunosorbent assay using chimeric antigens
Authors: B Ferra, L Holec-Gąsior, J Kur
Journal: Parasitology International 64 (5), 288–294
Year: 2015

Title: A new Toxoplasma gondii chimeric antigen containing fragments of SAG2, GRA1, and ROP1 proteins—impact of immunodominant sequences size on its …
Authors: B Ferra, L Holec-Gąsior, J Kur
Journal: Parasitology Research 114, 3291–3399
Year: 2015

Title: A new MIC1-MAG1 recombinant chimeric antigen can be used instead of the Toxoplasma gondii lysate antigen in serodiagnosis of human toxoplasmosis
Authors: L Holec-Gąsior, B Ferra, D Drapała, D Lautenbach, J Kur
Journal: Clinical and Vaccine Immunology 19 (1), 57–63
Year: 2012

Title: The first study on the usefulness of recombinant tetravalent chimeric proteins containing fragments of SAG2, GRA1, ROP1 and AMA1 antigens in the detection of specific anti …
Authors: BT Ferra, L Holec-Gąsior, J Gatkowska, B Dziadek, K Dzitko, ...
Journal: PLoS One 14 (6), e0217866
Year: 2019

Title: MIC1-MAG1-SAG1 chimeric protein, a most effective antigen for detection of human toxoplasmosis
Authors: L Holec-Gąsior, B Ferra, D Drapała
Journal: Clinical and Vaccine Immunology 19 (12), 1977–1979
Year: 2012